| 2024-06-21 | Gossamer Bio, Inc. GOSS | President & CEO | 372,000 0.2168% | $0.67 | $250,282 | +41.24% | ||
| 2024-03-27 | Sale | Gossamer Bio, Inc. GOSS | President & CEO | 23,172 0.0101% | $1.16 | $26,773 | -37.79% | |
| 2022-07-15 | Gossamer Bio, Inc. GOSS | President & CEO | 138,696 0.099% | $7.21 | $999,998 | -79.92% | ||
| 2022-03-23 | Sale | Gossamer Bio, Inc. GOSS | President & CEO | 19,035 0.0254% | $8.91 | $169,697 | -4.09% | |
| 2020-10-14 | Gossamer Bio, Inc. GOSS | director | 193,040 0.3131% | $10.36 | $2M | -1.07% | ||
| 2019-09-27 | Gossamer Bio, Inc. GOSS | director | 20,000 0.0161% | $8.40 | $167,980 | -20.65% | ||
| 2019-05-30 | Forte Biosciences, Inc. FBRX | director | 43,000 0.0242% | $4.66 | $200,315 | -77.34% | ||
| 2018-09-13 | Sale | Immunic, Inc. IMUX | director | 177,443 0.368% | $0.44 | $77,679 | -41.16% | |
| 2017-09-14 | Immunic, Inc. IMUX | director | 118,400 0.2764% | $4.19 | $495,741 | +36.47% | ||
| 2017-04-19 | Forte Biosciences, Inc. FBRX | director | 200,000 0.9793% | $10.00 | $2M | -14.41% | ||
| 2016-08-12 | Immunic, Inc. IMUX | director | 236,486 0.717% | $5.92 | $1.4M | -26.26% | ||
| 2008-07-09 | Sale | Biogen Inc. BIIB | EVP, Oncology/Rheumatology SBU | 36,837 0.0129% | $62.07 | $2.29M | -19.57% | |
| 2008-04-08 | Sale | Biogen Inc. BIIB | EVP, Oncology/Rheumatology SBU | 6,425 0.0022% | $64.68 | $415,582 | -22.7% | |
| 2007-05-23 | Sale | Biogen Inc. BIIB | EVP, Oncology/Rheumatology SBU | 7,446 0.0022% | $49.00 | $364,854 | +27.36% | |
| 2006-10-02 | Sale | Biogen Inc. BIIB | EVP, Oncology/Rheumatology SBU | 11,244 0.0034% | $44.63 | $501,797 | +11.89% |